This was a matched retrospective cohort study using existing medical records to compare melanoma risk in pregnant vs non-pregnant reproductive-age women. Women of childbearing age with melanoma diagnoses were matched to similar controls without melanoma. The study examined timing of melanoma in relation to pregnancy (before, during, and after) and disease stage at diagnosis. Primary endpoints were melanoma incidence and tumor characteristics by pregnancy status and timing.
The study did not show a simple, uniform increase in melanoma risk from pregnancy alone, but it did suggest that reproductive-age women may have higher melanoma risk in certain windows around pregnancy. Some melanomas diagnosed during pregnancy or shortly afterward were more likely to be thicker or at a more advanced stage, which is clinically important. Associations were modest and varied by timing; not all differences reached strong statistical significance, and effect sizes differed between subgroups. Overall, the data point to a need for heightened surveillance in reproductive-age women rather than a clear causal link between pregnancy and melanoma.
This was a retrospective study using existing records, which limits control over confounding factors such as UV exposure, tanning behaviors, or occupational sun exposure. Data may not fully capture all pregnancies (e.g., early losses, pregnancies managed outside the studied health systems) or all melanoma cases, affecting accuracy. The population and healthcare setting may not reflect all ethnic or geographic groups, so findings may not apply equally to women with darker skin tones or different sun environments. The study cannot prove that pregnancy causes melanoma; it only shows patterns of timing and risk, and additional prospective, diverse studies are needed.
Clinically, the findings support closer skin surveillance in reproductive-age women, especially during pregnancy and the early postpartum period, when hormonal and immune changes are most pronounced. Methodological strengths include a relatively large sample and matched design, but residual confounding (UV exposure, skin type, family history, prior tanning behavior) is likely. The results align with mixed prior literature, where some studies show worse melanoma stage at diagnosis in pregnant women, while others do not find a major increase in incidence. Overall, this study adds weight to a cautious approach: not alarmist about pregnancy itself, but more proactive about screening and timely biopsy of suspicious lesions in this age group.
For patients: check your skin monthly, and report any new or changing moles, especially during pregnancy or within a few years of giving birth. Use sun protection consistently (shade, clothing, broad-spectrum sunscreen) and avoid tanning beds, particularly if you are planning pregnancy or undergoing fertility treatment. For restorative care, consider melanoma risk as part of whole-person assessment: skin type, family history, immune status, vitamin D levels, and lifestyle exposure patterns. Integrate routine dermatology checks into preconception, pregnancy, and postpartum care for women with fair skin, multiple moles, or personal/family history of skin cancer.
This research looked at whether being pregnant changes a woman’s chances of getting melanoma, a serious type of skin cancer. It found that while pregnancy itself is not clearly causing melanoma, many melanomas in women are found during their childbearing years, and some are at a more advanced stage when discovered in pregnancy or shortly afterward. For someone on a fertility journey, this means skin checks and sun protection are important parts of caring for your overall health, just like tracking cycles and hormones. Root-cause evaluation should include family history, skin type, sun habits, and immune health so your care team can watch for problems early and coordinate with dermatology when needed.
Consider melanoma risk assessment as part of comprehensive preconception and pregnancy visits, particularly in fair-skinned women, those with numerous or atypical nevi, personal/family history of melanoma, or significant tanning/sunburn history. Maintain a low threshold for dermatology referral and biopsy of evolving pigmented lesions during pregnancy and postpartum; avoid attributing changes solely to pregnancy-related skin changes. Integrate this with restorative care by assessing immune/inflammatory status (e.g., vitamin D, autoimmune history), metabolic health, and lifestyle exposures, while reinforcing sun-safe behaviors. Document baseline skin findings when feasible and educate patients that prompt evaluation of changing moles is compatible with and supportive of fertility and pregnancy goals, not in conflict with them.
Educational insights, not a diagnosis or individualized treatment advice. Discuss findings with your own clinician. Visit Reproductive Health Insights to explore fertility resources.